Cargando…

Predictors and Long‐Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug‐Eluting Stents (ADAPT‐DES) Intravascular Ultrasound Substudy

BACKGROUND: The impact of acute stent malapposition (ASM) on long‐term clinical outcomes in patients undergoing percutaneous coronary intervention is still controversial. We sought to evaluate predictors and long‐term clinical outcomes of ASM. METHODS AND RESULTS: ADAPT‐DES (Assessment of Dual Antip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bin, Mintz, Gary S., Witzenbichler, Bernhard, Souza, Cristiano F., Metzger, D. Christopher, Rinaldi, Michael J., Duffy, Peter L., Weisz, Giora, Stuckey, Thomas D., Brodie, Bruce R., Matsumura, Mitsuaki, Yamamoto, Myong‐Hwa, Parvataneni, Rupa, Kirtane, Ajay J., Stone, Gregg W., Maehara, Akiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210413/ https://www.ncbi.nlm.nih.gov/pubmed/28007741 http://dx.doi.org/10.1161/JAHA.116.004438

Ejemplares similares

Long-term Clinical Outcomes of Drug-Eluting Stent Malapposition
por: Lee, Seung-Yul, et al.
Publicado: (2020)

Very late stent thrombosis with bare-metal stent: identifying severe stent malapposition and underexpansion by intravascular ultrasound
por: Caixeta, Adriano, et al.
Publicado: (2013)

Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2015)

Severe Acute Stent Malapposition After Drug‐Eluting Stent Implantation: Effects on Long‐Term Clinical Outcomes
por: Lee, Seung‐Yul, et al.
Publicado: (2019)

Long‐Term Clinical Outcomes of Late Stent Malapposition Detected by Optical Coherence Tomography After Drug‐Eluting Stent Implantation
por: Im, Eui, et al.
Publicado: (2019)

Computational simulation of stent thrombosis induced by various degrees of stent malapposition
por: Qu, Zhuoran, et al.
Publicado: (2022)

The “Oculo‐Appositional Reflex”: Should Optical Coherence Tomography–Detected Stent Malapposition Be Corrected?
por: Ali, Ziad A., et al.
Publicado: (2019)

The Initial Extent of Malapposition in ST-Elevation Myocardial Infarction Treated with Drug-Eluting Stent: The Usefulness of Optical Coherence Tomography
por: Kim, Ung, et al.
Publicado: (2010)

Intravascular Ultrasound-Guided Treatment for In-stent Restenosis Associated with Stent Fracture in Overlapped Drug-eluting Stents
por: Kim, Min Chul, et al.
Publicado: (2019)

Perioperative management of antiplatelet therapy in patients with drug-eluting stents
por: Dimitrova, G, et al.
Publicado: (2012)

Dual antiplatelet therapy and drug eluting stents: a marriage of convenience
por: Benezet-Mazuecos, Juan, et al.
Publicado: (2007)

Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy
por: Sibbing, Dirk, et al.
Publicado: (2009)

Efficacy and safety of antiplatelet-combination therapy after drug-eluting stent implantation
por: Cho, Yun-Kyeong, et al.
Publicado: (2014)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting Stents
por: Yoshikawa, Yusuke, et al.
Publicado: (2021)

The POT-PUFF Sign: A New Angiographic Indicator of Stent Malapposition During Proximal Optimization Therapy
por: Laraichi, Zakariae, et al.
Publicado: (2023)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
por: Shen, Ying, et al.
Publicado: (2015)

Is the Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents the Longer the Better?
por: Huang, Qing-Yu, et al.
Publicado: (2015)

Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015)

Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
por: Thim, Troels, et al.
Publicado: (2012)

Very Late Thrombosis of a Drug-Eluting Stent After Discontinuation of Dual Antiplatelet Therapy in a Patient Treated With Both Drug-Eluting and Bare-Metal Stents
por: Kim, Sung Soo, et al.
Publicado: (2009)

Comparison of Sirolimus and Paclitaxel-Eluting Stents for Complex Coronary Lesions: An Intravascular Ultrasound Study
por: Cho, Yun-Kyeong, et al.
Publicado: (2009)

Estrogen-Eluting Stents
por: Ryu, Sung Kee, et al.
Publicado: (2009)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions
por: Choi, Wonsuk, et al.
Publicado: (2019)

Risk Factors for Coronary Drug-Eluting Stent Thrombosis: Influence of Procedural, Patient, Lesion, and Stent Related Factors and Dual Antiplatelet Therapy
por: Sudhir, Krishnankutty, et al.
Publicado: (2013)

Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer?
por: Chang, Mineok, et al.
Publicado: (2014)

Patterns of Antiplatelet Therapy During Noncardiac Surgery in Patients With Second‐Generation Drug‐Eluting Stents
por: Kim, Choongki, et al.
Publicado: (2020)

The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Hu, Mengjin, et al.
Publicado: (2022)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
por: Kandzari, David E., et al.
Publicado: (2020)

Recanalization of in-stent chronic total occlusion using intravascular lithotripsy and Firehawk(®) rapamycin target eluting coronary stents: A case report
por: Patrascu, Alexandru, et al.
Publicado: (2021)

Stent Fracture after Everolimus-Eluting Stent Implantation
por: Almasood, Ali S., et al.
Publicado: (2011)

Early definite stent thrombosis with everolimus-eluting stents
por: Naito, Ryo, et al.
Publicado: (2015)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Role of optical coherence tomography guided percutaneous coronary intervention to assess stent malapposition in de-novo coronary lesions
por: Ratheesh, Kumar J., et al.
Publicado: (2018)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients
por: Wang, Yue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sf0g4skaipjcnc56pq0bjr3hqc